| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 185.830 | 543.676 | 715.932 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 185.830 | 543.740 | 715.937 |
| Total Expenses - EUR | - | - | - | - | - | - | 5.214 | 205.565 | 482.125 | 627.033 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -5.214 | -19.735 | 61.615 | 88.904 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -5.214 | -21.595 | 57.699 | 75.281 |
| Employees | - | - | - | - | - | - | 2 | 5 | 8 | 10 |
Check the financial reports for the company - Nilep Lab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 225 | 118.556 | 108.019 | 233.409 |
| Current Assets | - | - | - | - | - | - | 14.586 | 76.667 | 131.982 | 53.753 |
| Inventories | - | - | - | - | - | - | 14.515 | 46.924 | 77.021 | 1.229 |
| Receivables | - | - | - | - | - | - | 0 | 22.348 | 24.304 | 40.694 |
| Cash | - | - | - | - | - | - | 71 | 7.396 | 30.656 | 11.830 |
| Shareholders Funds | - | - | - | - | - | - | -5.174 | -26.785 | 30.995 | 48.734 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 20.098 | 222.008 | 209.005 | 238.428 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nilep Lab S.r.l.